Skip to main content

As Investments Opportunities Pile Up for Its Biotech Portfolio Model Strategy, Healthtech Solutions Inc. (HLTT) Taps New CEO After First Acquisition

  • Dr. Edward “Ned” Swanson has joined Healthtech as CEO, bringing decades of scientific, clinical, industry and capital markets experience, including founding NASDAQ-listed company, to HLTT
  • Healthtech in recent months has committed to a portfolio strategy, where it will bring diverse group of healthtech companies forward
  • Company acquired precision oncology company Varian Biopharmaceuticals Inc. (“VarianBio”) in May, adding it to their family of companies that already included MediScan and RevHeart
  • The biotech portfolio model is hot, with over $5.5 billion in capital raised in the last six years

Historically, biotech companies built value nearly exclusively with a straightforward approach centered on a specific market segment. While that still may be true in many cases, the landscape has shifted with more companies employing a portfolio model that leverages a broader skillset of a management team to oversee a diverse group of businesses. As it advances a groundbreaking imaging technology, HealthTech Solutions (OTC: HLTT) has adopted the model this year to bring healthcare technology forward, including an aggressive acquisitions strategy being spearheaded by newly appointed CEO.

This month, Healthtech recruited Edward “Ned” Swanson, M.D. as chief executive officer (https://ibn.fm/KvQt9). Dr. Swanson, who earned his M.D. from Harvard Medical School and was previously a resident in plastic and reconstructive surgery at The Johns Hopkins University School of Medicine, knows success across multiple verticals. Most recently, he co-founded NASDAQ-listed PolarityTE, a biotech company…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.